Testing effectiveness (Phase 2)Ended earlyNCT04004000
What this trial is testing
Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension
Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1
Fulcrum Therapeutics 14